» Articles » PMID: 6277788

Monoclonal Antibodies to Herpes Simplex Virus Type 1 Proteins, Including the Immediate-early Protein ICP 4

Overview
Journal Infect Immun
Date 1981 Dec 1
PMID 6277788
Citations 257
Authors
Affiliations
Soon will be listed here.
Abstract

Monoclonal antibodies were prepared against herpes simplex virus type 1 (strain 14012) by two immunization procedures. Procedure A utilized infectious virus propagated in mouse cells, and procedure B utilized mouse cells infected with herpes simplex virus in the presence of cycloheximide and harvested 1 h after removal of the inhibitor. A total of 52 monoclonal antibodies were obtained against 10 herpes simplex virus proteins, including four glycosylated proteins (a 110,000-molecular-weight protein, gB, gC, and gD) and six nonglycosylated proteins (a 68,000-molecular-weight protein, ICP 9, ICP 8, ICP 6, ICP 5, and the immediate-early ICP 4). The antibodies were assayed against herpes simplex virus types 1 and 2 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of radioimmunoprecipitates, immunofluorescence, and neutralization. Using the reagents prepared, we concluded that the 110,000-molecular-weight protein, gD, ICP 9, ICP 9, ICP 6, and the 68,000-molecular-weight protein express both type-specific and cross-reactive antigenic determinants. In contrast, nine antibodies against gB all cross-reacted with herpes simplex virus type 2, whereas eight antibodies to gC all reacted type specifically.

Citing Articles

Daxx mediated histone H3.3 deposition on HSV-1 DNA restricts genome decompaction and the progression of immediate-early transcription.

Roberts A, Orr A, Iliev V, Orr L, McFarlane S, Yang Z bioRxiv. 2024; .

PMID: 39185184 PMC: 11343217. DOI: 10.1101/2024.08.15.608064.


Sp1 facilitates continued HSV-1 gene expression in the absence of key viral transactivators.

Sodroski C, Oh H, Chou S, Knipe D mBio. 2024; 15(3):e0347923.

PMID: 38349188 PMC: 10936440. DOI: 10.1128/mbio.03479-23.


Nuclear interferon-stimulated gene product maintains heterochromatin on the herpes simplex viral genome to limit lytic infection.

Sodroski C, Knipe D Proc Natl Acad Sci U S A. 2023; 120(45):e2310996120.

PMID: 37883416 PMC: 10636318. DOI: 10.1073/pnas.2310996120.


Herpes simplex virus infected cell protein 8 is required for viral inhibition of the cGAS pathway.

Broekema N, Mertens M, Angelova M, Orzalli M, Oh H, Knipe D Virology. 2023; 585:34-41.

PMID: 37271042 PMC: 10526635. DOI: 10.1016/j.virol.2023.05.002.


Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.

Vannini A, Parenti F, Forghieri C, Barboni C, Zaghini A, Campadelli-Fiume G Front Mol Biosci. 2023; 10:1149973.

PMID: 37251078 PMC: 10213976. DOI: 10.3389/fmolb.2023.1149973.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Cohen G, Ponce de Leon M, Nichols C . Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. J Virol. 1972; 10(5):1021-30. PMC: 356573. DOI: 10.1128/JVI.10.5.1021-1030.1972. View

3.
Honess R, Roizman B . Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell. J Virol. 1973; 12(6):1347-65. PMC: 356776. DOI: 10.1128/JVI.12.6.1347-1365.1973. View

4.
Heine J, Honess R, Cassai E, Roizman B . Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol. 1974; 14(3):640-51. PMC: 355559. DOI: 10.1128/JVI.14.3.640-651.1974. View

5.
Courtney R, Benyesh-Melnick M . Isolation and characterization of a large molecular-weight polypeptide of herpes simplex virus type 1. Virology. 1974; 62(2):539-51. DOI: 10.1016/0042-6822(74)90414-0. View